Recce Completes Capital Raising of $27.95m

sophisticated and professional investors participating in the offer. Recce Pharmaceuticals Chief Executive Officer James Graham said, “We greatly appreciate the support shown by both our existing investors and new institutional investors. Their financial support comes at a transformative time for Recce as we prepare updating the market as our pivotal trials progress in the coming months.” At $1.30